Skip to main content

Allan D. Kirk

NIH Rank #2122
  • Program Leader
  • Early Career
  • Mentor
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1912522Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Surgery

NIH Funding · FY2024

Linked Award Amount
$3.4M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#2,122
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Allan D. Kirk. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Allan D. Kirk as a PI. Multi-PI records show the full award amount for context.

  • 5U19AI131471-08U19
    The Risks and Opportunities of Homeostatic Repopulation
    $1.1M
    award amount
  • 5U01AI090956-15U01
    Neonatal porcine islet xenografts for the treatment of type 1 diabetes
    $1.1M
    award amount
  • 5U01AI170064-03U01
    Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
    $473.4K
    award amount
  • 1R56AI184588-01R56
    The impact of targeting CD40-CD154 pathway in nonhuman primate vascularized composite allograft model
    $402.5K
    award amount
  • 2T32AI141342-06T32
    Advanced Immunobiology Traning Program for Surgeons
    $282K
    award amount

Award organization

Organizations that administered FY2024 awards listing Allan D. Kirk as a PI.

FY2024 award administered by Duke University (NC).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Duke University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2122
  6. 2024
    Entered Top 25% Nationally
    Ranked #2122
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Program/Center Grant Leader
Allan D. Kirk | NIH Award Records | ConductScience